 IRIDEX Corporation IRIX, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generation of the MicroPulse P3 Device, which has been redesigned to deliver greater stability, visualization, coupling, and fit. More than 120,000 patients have been treated in over 60 countries with the original version of the MicroPulse P3 Device. 